{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:40:41Z","timestamp":1780472441066,"version":"3.54.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.rdc.2006.05.008","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T10:09:23Z","timestamp":1168423763000},"page":"491-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Cardiac Manifestations in the Antiphospholipid Syndrome"],"prefix":"10.1016","volume":"32","author":[{"given":"Felicia","family":"Tenedios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doruk","family":"Erkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Lockshin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2006.05.008_bib1","first-page":"2402","article-title":"Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study","volume":"31","author":"Espinola Zavaleta","year":"2004","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2006.05.008_bib2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.05.008_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000075690","article-title":"The role of complement in the antiphospholipid syndrome","volume":"7","author":"Salmon","year":"2004","journal-title":"Curr Dir Autoimmun"},{"issue":"3","key":"10.1016\/j.rdc.2006.05.008_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2249.2004.02497.x","article-title":"Antiphospholipid syndrome: multiple mechanisms","volume":"136","author":"Mackworth-Young","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"5\u20136","key":"10.1016\/j.rdc.2006.05.008_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.thromres.2004.06.045","article-title":"Inflammatory response and the endothelium","volume":"114","author":"Meroni","year":"2004","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.rdc.2006.05.008_bib6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2006.05.008_bib7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1191\/0961203303lu391oa","article-title":"Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report","volume":"12","author":"Lockshin","year":"2003","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.rdc.2006.05.008_bib8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1191\/0961203305lu2194oa","article-title":"Nonorgan specific autoantibodies and heart damage","volume":"14","author":"Tincani","year":"2005","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.rdc.2006.05.008_bib9","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/ard.2004.032813","article-title":"Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome","volume":"64","author":"Krause","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.rdc.2006.05.008_bib10","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.93.8.1579","article-title":"Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome","volume":"93","author":"Hojnik","year":"1996","journal-title":"Circulation"},{"issue":"8705","key":"10.1016\/j.rdc.2006.05.008_bib11","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/0140-6736(90)91373-I","article-title":"Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus","volume":"335","author":"Khamashta","year":"1990","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rdc.2006.05.008_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.82.2.369","article-title":"Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies","volume":"82","author":"Nihoyannopoulos","year":"1990","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.rdc.2006.05.008_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/ard.51.2.156","article-title":"Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients","volume":"51","author":"Cervera","year":"1992","journal-title":"Ann Rheum Dis"},{"issue":"5\u20136","key":"10.1016\/j.rdc.2006.05.008_bib14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.thromres.2004.06.026","article-title":"Coronary and valvular syndromes and antiphospholipid antibodies","volume":"114","author":"Cervera","year":"2004","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.rdc.2006.05.008_bib15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1191\/096120300678828532","article-title":"Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography","volume":"9","author":"Turiel","year":"2000","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.rdc.2006.05.008_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0049-0172(97)80034-0","article-title":"Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment","volume":"27","author":"Nesher","year":"1997","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2006.05.008_bib17","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0735-1097(92)90368-W","article-title":"Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies","volume":"20","author":"Roldan","year":"1992","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.rdc.2006.05.008_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/096120339100100108","article-title":"High prevalence of significant heart valve lesions in patients with the \u201cprimary\u201d antiphospholipid syndrome","volume":"1","author":"Cervera","year":"1991","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.rdc.2006.05.008_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-116-4-293","article-title":"Valvular heart disease in the primary antiphospholipid syndrome","volume":"116","author":"Galve","year":"1992","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.rdc.2006.05.008_bib20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/01.STR.0000154858.27353.df","article-title":"Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: a transesophageal echocardiographic study","volume":"36","author":"Erdogan","year":"2005","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.rdc.2006.05.008_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/096120339600500306","article-title":"Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves","volume":"5","author":"Ziporen","year":"1996","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.rdc.2006.05.008_bib22","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0002-8703(99)70424-2","article-title":"Echocardiographic evaluation of patients with primary antiphospholipid syndrome","volume":"137","author":"Espinola-Zavaleta","year":"1999","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.rdc.2006.05.008_bib23","first-page":"99","article-title":"Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease","volume":"17","author":"Amital","year":"1999","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2006.05.008_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1191\/096120399678840873","article-title":"Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome","volume":"8","author":"Afek","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.008_bib25","unstructured":"Binstadt BA, Nguyen LT, Huang H, et al. Spontaneous cardiac valve inflammation in the K\/BxN murine arthritis model. In: European Workshop for Rheumatology Research in Crete Session III, Abstract 70, February 24, 2006."},{"issue":"1","key":"10.1016\/j.rdc.2006.05.008_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/ard.2005.045443","article-title":"Infectious origin of the antiphospholipid syndrome","volume":"65","author":"Shoenfeld","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"5\u20136","key":"10.1016\/j.rdc.2006.05.008_bib27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.thromres.2004.06.039","article-title":"Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection","volume":"114","author":"Blank","year":"2004","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.rdc.2006.05.008_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.0742-2822.2005.04021.x","article-title":"Valve morphology in antiphospholipid antibody syndrome: echocardiographic features","volume":"22","author":"Qaddoura","year":"2005","journal-title":"Echocardiography"},{"issue":"4","key":"10.1016\/j.rdc.2006.05.008_bib29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.amjcard.2005.04.022","article-title":"Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome","volume":"96","author":"Turiel","year":"2005","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.rdc.2006.05.008_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1540-8191.1995.tb01231.x","article-title":"Etiology and management of chronic valve disease in antiphospholipid antibody syndrome and systemic lupus erythematosus","volume":"10","author":"Shahian","year":"1995","journal-title":"J Card Surg"},{"issue":"12","key":"10.1016\/j.rdc.2006.05.008_bib31","first-page":"2817","article-title":"Primary antiphospholipid syndrome: functional outcome after 10 years","volume":"27","author":"Erkan","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.008_bib32","unstructured":"Farzaneh-Far A, Roman MJ, Lockshin MD, et al. Impact of antiphospholipid antibodies on cardiovascular disease in systemic lupus erythematosus. Submitted for publication."},{"key":"10.1016\/j.rdc.2006.05.008_bib33","unstructured":"Farzaneh-Far A, Roman MJ, Lockshin MD, et al. Impact of antiphospholipid antibodies and inflammatory markers on valvular disease in systemic lupus erythematosus. Submitted for publication."},{"issue":"2","key":"10.1016\/j.rdc.2006.05.008_bib34","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jtcvs.2003.07.016","article-title":"Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery","volume":"127","author":"Berkun","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.rdc.2006.05.008_bib35","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1191\/0961203305lu2191ed","article-title":"Heart, rheumatism and autoimmunity: an old intriguing link","volume":"14","author":"Doria","year":"2005","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.rdc.2006.05.008_bib36","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.rdc.2006.05.008_bib37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0002-9149(00)01453-3","article-title":"Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome","volume":"87","author":"Roman","year":"2001","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.rdc.2006.05.008_bib38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.rdc.2005.01.006","article-title":"Inflammation and accelerated atherosclerosis: basic mechanisms","volume":"31","author":"Doria","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"issue":"9","key":"10.1016\/j.rdc.2006.05.008_bib39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1191\/0961203305lu2213oa","article-title":"Innate immunity and atherogenesis","volume":"14","author":"Rattazzi","year":"2005","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.rdc.2006.05.008_bib40","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1191\/0961203305lu2211oa","article-title":"Oxidized LDL\/beta2-glycoprotein I complexes: new aspects in atherosclerosis","volume":"14","author":"Matsuura","year":"2005","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.rdc.2006.05.008_bib41","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1191\/0961203305lu2212oa","article-title":"Role of antiheat shock protein 60 autoantibodies in atherosclerosis","volume":"14","author":"Mandal","year":"2005","journal-title":"Lupus"},{"issue":"17","key":"10.1016\/j.rdc.2006.05.008_bib42","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.99.17.2227","article-title":"Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression","volume":"99","author":"George","year":"1999","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.rdc.2006.05.008_bib43","first-page":"103","article-title":"Are oxidized LDL\/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?","volume":"11","author":"Matsuura","year":"2004","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2006.05.008_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/ard.2004.023952","article-title":"Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data","volume":"64","author":"Ames","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.rdc.2006.05.008_bib45","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/rheumatology\/keh722","article-title":"Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model","volume":"44","author":"Delgado Alves","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.rdc.2006.05.008_bib46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0889-857X(05)70135-6","article-title":"Hopkins lupus cohort. 1999 update","volume":"26","author":"Petri","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"issue":"25","key":"10.1016\/j.rdc.2006.05.008_bib47","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.rdc.2006.05.008_bib48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/ard.2003.016204","article-title":"Prevalence of an abnormal ankle\u2013brachial index in patients with primary antiphospholipid syndrome: preliminary data","volume":"64","author":"Baron","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2006.05.008_bib49","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1191\/0961203302lu165oa","article-title":"Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies","volume":"11","author":"Ames","year":"2002","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.rdc.2006.05.008_bib50","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/ard.62.7.607","article-title":"Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome","volume":"62","author":"Medina","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.05.008_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.CIR.91.1.23","article-title":"Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men","volume":"91","author":"Vaarala","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2006.05.008_bib52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(86)92258-0","article-title":"Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events","volume":"1","author":"Hamsten","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2006.05.008_bib53","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.CIR.102.11.1258","article-title":"Anticardiolipin antibodies and recurrent coronary events. A prospective study of 1150 patients","volume":"102","author":"Bili","year":"2000","journal-title":"Circulation"},{"issue":"8791","key":"10.1016\/j.rdc.2006.05.008_bib54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0140-6736(92)91057-F","article-title":"Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke","volume":"339","author":"Sletnes","year":"1992","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.rdc.2006.05.008_bib55","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/0002-9149(90)91439-D","article-title":"Prevalence of anticardiolipin antibodies in coronary artery disease","volume":"65","author":"De Caterina","year":"1990","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.rdc.2006.05.008_bib56","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1002\/art.11449","article-title":"Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model","volume":"48","author":"Ferrara","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2006.05.008_bib57","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1191\/0961203305lu2217oa","article-title":"Statins and autoimmune diseases","volume":"14","author":"Riboldi","year":"2005","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.rdc.2006.05.008_bib58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/ard.60.1.43","article-title":"Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome","volume":"60","author":"Tektonidou","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2006.05.008_bib59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/hrt.74.5.531","article-title":"M mode and Doppler echocardiographic assessment of left ventricular diastolic function in primary antiphospholipid syndrome","volume":"74","author":"Coudray","year":"1995","journal-title":"Br Heart J"},{"issue":"5","key":"10.1016\/j.rdc.2006.05.008_bib60","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0002-8703(95)90124-8","article-title":"Diastolic dysfunction is a feature of the antiphospholipid syndrome","volume":"129","author":"Hasnie","year":"1995","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.rdc.2006.05.008_bib61","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0002-9343(90)90368-N","article-title":"Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus","volume":"89","author":"Leung","year":"1990","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.rdc.2006.05.008_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199805000-00005","article-title":"Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients","volume":"77","author":"Asherson","year":"1998","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.rdc.2006.05.008_bib63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000006948","article-title":"Asymptomatic intracardiac thrombi and primary antiphospholipid syndrome","volume":"92","author":"Granel","year":"1999","journal-title":"Cardiology"},{"issue":"12","key":"10.1016\/j.rdc.2006.05.008_bib64","first-page":"2658","article-title":"The role of cardiac magnetic resonance imaging in antiphospholipid syndrome","volume":"29","author":"Erkan","year":"2002","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2006.05.008_bib65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.61.3.195","article-title":"The lung in the antiphospholipid syndrome","volume":"61","author":"Espinosa","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2006.05.008_bib66","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1191\/0961203302lu216xx","article-title":"Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome","volume":"11","author":"McMillan","year":"2002","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.rdc.2006.05.008_bib67","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/0003-4819-130-9-199905040-00014","article-title":"Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series","volume":"130","author":"McLaughlin","year":"1999","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.rdc.2006.05.008_bib68","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0002-9610(99)80285-2","article-title":"Antiphospholipid antibodies lead to increased risk in cardiovascular surgery","volume":"170","author":"Ciocca","year":"1995","journal-title":"Am J Surg"},{"issue":"4","key":"10.1016\/j.rdc.2006.05.008_bib69","first-page":"843","article-title":"Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations","volume":"29","author":"Erkan","year":"2002","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2006.05.008_bib70","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/00000539-200005000-00017","article-title":"Antiphospholipid syndrome and cardiac surgery: management of anticoagulation in two patients","volume":"90","author":"East","year":"2000","journal-title":"Anesth Analg"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X06000494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X06000494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:03:50Z","timestamp":1760180630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X06000494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0889857X06000494"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2006.05.008","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Manifestations in the Antiphospholipid Syndrome","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2006.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}